Mycophenolic Acid Tablet, Delayed Release
Product Images NDC 60505-2965

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mycophenolic Acid (NDC 60505-2965). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mycophenolate-360mg (Btl Lbl 360mg 120s)

This is a description of a medication called Mycophenolic Acid. Each delayed-release tablet contains 360 mg of Mycophenolic Acid as Mycophenolate Sodium. The recommended dosage is one or two tablets to be taken by mouth with water, but not to be crushed, chewed, or cut. The tablets should be stored within the temperature range of 20° to 25°C (68° to 77°F). The package insert has more information on usage, and there is a Medication Guide available at www.apotex.com/Products/US.*

FDA Label Image

Mycophenolate-180mg (Mycophenolate 180mg)

This is a medication label for mycophenolic acid in 180 mg extended release tablets. It advises taking one or two tablets with water before meals and not to crush, chew, or break the tablets. The medication should be stored at room temperature and must be kept in a light-resistant container. The recommended dosage should be consulted with the packaging insert. It also provides the manufacturer (Apotex Corp) and the tablet's product code (NDC 60505-2965-7).*

FDA Label Image

Mycophenolic-structure (Mycophenolicfigure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.